文献速递创伤与烧伤复苏、休克与脓毒症

SEE-IT 试验:急诊医疗服务创伤调度视频实时直播评估的可行性随机对照试验

The SEE-IT Trial: emergency medical services Streaming Enabled Evaluation In Trauma: a feasibility randomised controlled trial.
PubMed 文献 · Scand J Trauma Resusc Emerg Med · 2024-01-26
一句话结论旁观者视频实时直播在创伤调度中可行且被999呼叫者与调度员接受,但HEMS停飞率及心理伤害数据不足,尚需确定性RCT评估。

本研究为可行性随机对照试验,将6个试验周内的值班班次按1:1随机分为创伤事件中使用视频实时直播(GoodSAM Instant-On-Scene)或仅标准护理。共随机62个班次、纳入240起事件(对照132起;干预108起)。预设4项进展标准中2项达标:86%拥有智能手机的呼叫者同意并能激活直播;85%的激活请求成功获得视频。另2项因数据不足无法判定:HEMS因直播停飞2/6(33%);调查、观察和访谈未发现心理伤害证据,但呼叫者或对照EMS站点的调查数据不足。

要点

  • 86%拥有智能手机的呼叫者同意并能激活视频实时直播,85%的激活请求成功获得视频,两项预设进展标准达标。
  • HEMS因直播停飞为2/6(33%),因数据不足无法判定是否达到降低≥10%的预设标准。
  • 调查、观察和访谈未发现呼叫者或员工/调度员的心理伤害证据,但呼叫者或对照EMS站点调查数据不足。
  • 患者招募(判断调度适当性)58/269(22%)、呼叫者招募(测量潜在伤害)4/244(2%)均低。
  • 内城EMS调度员访谈报告语言障碍和高龄是视频实时直播的潜在挑战。

适用人群与场景

  • 6个试验周内值班班次中符合条件的创伤事件,随机为干预(视频实时直播)或仅标准护理。
  • 观察性子研究包括常规使用视频实时直播的内城EMS(探索多元人群中的可接受性)和未使用视频实时直播的EMS站点员工福祉比较。

诊断标准与关键阈值

  • 预设进展标准1:≥70%拥有智能手机的呼叫者(旁观者)同意并能激活实时直播。
  • 预设进展标准2:≥50%的激活请求导致视频被观看。
  • 预设进展标准3:因实时视频使HEMS停飞率降低≥10%。
  • 预设进展标准4:呼叫者或员工/调度员无心理伤害证据。

处置流程与药物剂量

  • 干预组在符合条件的创伤事件中使用GoodSAM Instant-On-Scene进行视频实时直播;对照组仅标准护理。

研究设计与关键结果

  • 可行性随机对照试验,随机62个班次,纳入240起事件(对照132起;干预108起);干预组53起事件成功直播。
  • 进展标准1达标:86%拥有智能手机的呼叫者同意并能激活实时直播。
  • 进展标准2达标:85%的激活请求成功获得视频。
  • 进展标准3因数据不足无法判定:HEMS因直播停飞2/6(33%)。
  • 进展标准4因数据不足无法判定:调查、观察或访谈未发现心理伤害证据,但呼叫者或对照EMS站点调查数据不足。
  • 患者招募58/269(22%)、呼叫者招募4/244(2%)均低。
  • 内城EMS调度员访谈报告语言障碍和高龄是视频实时直播的潜在挑战。

证据类型、等级与局限

  • 证据类型:可行性随机对照试验,嵌入过程评估和探索性经济学评估。
  • 局限:患者和呼叫者招募率低;HEMS停飞和心理伤害数据不足;需进一步评估意外后果、获益和伤害。

对床旁实践的改变

  • 旁观者视频实时直播从现场到EMS可行、对999呼叫者和调度员可接受,可能有助于调度决策(作者结论)。
  • 这些发现支持进展到确定性RCT(作者结论)。
  • 语言障碍和高龄被内城EMS调度员访谈报告为视频实时直播的潜在挑战。

指南或共识出处

  • SEE-IT试验,注册号ISRCTN 11449333(2022年3月22日)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Use of bystander video livestreaming from scene to Emergency Medical Services (EMS) is becoming increasingly common to aid decision making about the resources required. Possible benefits include earlier, more appropriate dispatch and clinical and financial gains, but evidence is sparse.

METHODS: A feasibility randomised controlled trial with an embedded process evaluation and exploratory economic evaluation where working shifts during six trial weeks were randomised 1:1 to use video livestreaming during eligible trauma incidents (using GoodSAM Instant-On-Scene) or standard care only. Pre-defined progression criteria were: (1) ≥ 70% callers (bystanders) with smartphones agreeing and able to activate live stream; (2) ≥ 50% requests to activate resulting in footage being viewed; (3) Helicopter Emergency Medical Services (HEMS) stand-down rate reducing by ≥ 10% as a result of live footage; (4) no evidence of psychological harm in callers or staff/dispatchers. Observational sub-studies included (i) an inner-city EMS who routinely use video livestreaming to explore acceptability in a diverse population; and (ii) staff wellbeing in an EMS not using video livestreaming for comparison to the trial site.

RESULTS: Sixty-two shifts were randomised, including 240 incidents (132 control; 108 intervention). Livestreaming was successful in 53 incidents in the intervention arm. Patient recruitment (to determine appropriateness of dispatch), and caller recruitment (to measure potential harm) were low (58/269, 22% of patients; 4/244, 2% of callers). Two progression criteria were met: (1) 86% of callers with smartphones agreed and were able to activate livestreaming; (2) 85% of requests to activate livestreaming resulted in footage being obtained; and two were indeterminate due to insufficient data: (3) 2/6 (33%) HEMS stand down due to livestreaming; (4) no evidence of psychological harm from survey, observations or interviews, but insufficient survey data from callers or comparison EMS site to be confident. Language barriers and older age were reported in interviews as potential challenges to video livestreaming by dispatchers in the inner-city EMS.

CONCLUSIONS: Progression to a definitive RCT is supported by these findings. Bystander video livestreaming from scene is feasible to implement, acceptable to both 999 callers and dispatchers, and may aid dispatch decision-making. Further assessment of unintended consequences, benefits and harm is required.

TRIAL REGISTRATION: ISRCTN 11449333 (22 March 2022). https://www.isrctn.com/ISRCTN11449333.

来源:Scand J Trauma Resusc Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Taylor C, Ollis L, Lyon RM, et al. The SEE-IT Trial: emergency medical services Streaming Enabled Evaluation In Trauma: a feasibility randomised controlled trial. Scand J Trauma Resusc Emerg Med. 2024. PMID: 38383402. doi:10.1186/s13049-024-01179-0

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。